Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Alcolea

Showing results (81-90 of 242) with videos related to

Pageof 25
Sort By:
Alzheimer'S Research & Therapy|November 17, 2021
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathyAnna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
Neurology|October 12, 2023
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic ApproachBlanca Acha, Jon Corroza, Javier Sánchez-Ruiz de Gordoa, et al.
Journal of Lipid Research|July 23, 2025
Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4Carla Borràs, Marina Canyelles, David Santos, et al.
Alzheimer'S Research & Therapy|September 25, 2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathyAnna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
Journal of Neuroinflammation|January 24, 2025
Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosisEsther Álvarez-Sánchez, Álvaro Carbayo, Natalia Valle-Tamayo, et al.
Neurology|October 7, 2018
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrumIgnacio Illán-Gala, Daniel Alcolea, Victor Montal, et al.
Acta Neuropathologica|December 11, 2012
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer diseaseMarta Pera, Daniel Alcolea, Raquel Sánchez-Valle, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2023
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter studyNúria Guillén, José Contador, Mariateresa Buongiorno, et al.
Journal of Alzheimer'S Disease : JAD|January 21, 2020
CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's DiseaseJúlia Faura, Alejandro Bustamante, Anna Penalba, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 17, 2020
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosisOriol Dols-Icardo, Víctor Montal, Sònia Sirisi, et al.
Pageof 25

Showing results (81-90 of 242) with videos related to

Sort By:
Pageof 25
Alzheimer'S Research & Therapy|November 17, 2021
Correction to: Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathyAnna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
Neurology|October 12, 2023
Association of Blood-Based DNA Methylation Markers With Late-Onset Alzheimer Disease: A Potential Diagnostic ApproachBlanca Acha, Jon Corroza, Javier Sánchez-Ruiz de Gordoa, et al.
Journal of Lipid Research|July 23, 2025
Cerebrospinal fluid lipoprotein-mediated cholesterol delivery to neurons is impaired in Alzheimer's disease and involves APOE4Carla Borràs, Marina Canyelles, David Santos, et al.
Alzheimer'S Research & Therapy|September 25, 2021
Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathyAnna M De Kort, H Bea Kuiperij, Daniel Alcolea, et al.
Journal of Neuroinflammation|January 24, 2025
Single-cell RNA sequencing highlights the role of distinct natural killer subsets in sporadic amyotrophic lateral sclerosisEsther Álvarez-Sánchez, Álvaro Carbayo, Natalia Valle-Tamayo, et al.
Neurology|October 7, 2018
CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrumIgnacio Illán-Gala, Daniel Alcolea, Victor Montal, et al.
Acta Neuropathologica|December 11, 2012
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer diseaseMarta Pera, Daniel Alcolea, Raquel Sánchez-Valle, et al.
European Archives of Psychiatry and Clinical Neuroscience|October 29, 2023
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter studyNúria Guillén, José Contador, Mariateresa Buongiorno, et al.
Journal of Alzheimer'S Disease : JAD|January 21, 2020
CCL23: A Chemokine Associated with Progression from Mild Cognitive Impairment to Alzheimer's DiseaseJúlia Faura, Alejandro Bustamante, Anna Penalba, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|July 17, 2020
Motor cortex transcriptome reveals microglial key events in amyotrophic lateral sclerosisOriol Dols-Icardo, Víctor Montal, Sònia Sirisi, et al.
Pageof 25